The Manufacturers Life Insurance Company lessened its holdings in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 2.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,576 shares of the technology company's stock after selling 3,853 shares during the quarter. The Manufacturers Life Insurance Company owned 0.06% of AMETEK worth $23,338,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Olde Wealth Management LLC bought a new stake in AMETEK during the 1st quarter valued at $29,000. Annis Gardner Whiting Capital Advisors LLC grew its stake in shares of AMETEK by 57.7% in the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock worth $33,000 after acquiring an additional 71 shares in the last quarter. Zions Bancorporation National Association UT bought a new stake in shares of AMETEK in the 1st quarter worth $42,000. Minot DeBlois Advisors LLC bought a new stake in shares of AMETEK in the 4th quarter worth $43,000. Finally, Costello Asset Management INC bought a new stake in shares of AMETEK in the 1st quarter worth $43,000. Institutional investors own 87.43% of the company's stock.
AMETEK Stock Performance
AME traded down $0.47 during trading on Friday, hitting $187.41. 1,064,297 shares of the company traded hands, compared to its average volume of 1,023,565. The firm has a market cap of $43.28 billion, a P/E ratio of 30.18, a price-to-earnings-growth ratio of 2.70 and a beta of 1.10. The stock's fifty day moving average is $182.63 and its 200 day moving average is $177.06. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a one year low of $145.02 and a one year high of $198.33.
AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.09. The company had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.74 billion. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The firm's revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.66 earnings per share. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. As a group, equities analysts predict that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 15th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Monday, September 15th. AMETEK's dividend payout ratio (DPR) is currently 19.97%.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on AME shares. Wall Street Zen upgraded shares of AMETEK from a "hold" rating to a "buy" rating in a research note on Monday, May 12th. Robert W. Baird upped their target price on shares of AMETEK from $190.00 to $198.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. KeyCorp upped their target price on shares of AMETEK from $195.00 to $205.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. TD Cowen upgraded shares of AMETEK from a "sell" rating to a "hold" rating and upped their target price for the stock from $158.00 to $180.00 in a research note on Tuesday, September 2nd. Finally, Mizuho increased their price target on shares of AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a research report on Friday, August 1st. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $205.45.
Check Out Our Latest Stock Report on AMETEK
About AMETEK
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.